Pfizer, Haleon
Pfizer to Receive 2.66 Billion Pounds From Haleon in Share Deal
Pfizer will receive around 2.66 billion pounds ($3.56 billion) in aggregate from Haleon from an offering and a share buyback. Goldman Sachs International said Tuesday that the pharmaceutical company sold 640 million ordinary shares in British consumer-healthcare business Haleon at 380 pence a share.
Haleon’s Rating Reconfirmed After Changes in Pfizer's Stake
Haleon PLC, leading to a significant share repurchase.,UBS has reaffirmed its positive rating on Haleon following this development.,Haleon plans to cancel half of the repurchased shares as part of its
Pfizer to Pare Back Haleon Stake With 540 Million Share Offering
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant.
Pfizer raises US$3.2 billion by selling part of Haleon stake
Pfizer has raised about US$3.2 billion from the sale of Haleon shares, as it further reduces its stake in the UK consumer health company. Read more at The Business Times.
Pfizer Intends to Sell Around 540 Million Ordinary Shares in Haleon -- Update
Pfizer said it intends to sell around 540 million ordinary shares in British consumer-healthcare business Haleon, or about 5.9% of the company's issued share capital. The pharmaceutical giant said Monday that the price per share will be determined by way of an accelerated bookbuilding process to institutional investors.
Pfizer to sell about $3.25 billion stake in Sensodyne-maker Haleon, bookrunner says
Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) worth of ordinary shares from Pfizer. In March, the U.S. pharma major had sold about $3.
Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Haleon Announces Leadership Transition in Canada: Rupa Bahri to Depart, Christine Jakovcic Appointed as New General Manager
Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon ...
Drug giant Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...
Pfizer's Total Interest In Haleon To Reduce From Approx. 22.6% To Approx. 15.0%
Pfizer said, further to the Launch Announcement on 30 September 2024, it has sold 640 million ordinary shares in Haleon plc, at a ...
GlobalCapital19h
Fireworks in ECM with Haleon block and NBG privatisation
Goldman Sachs, JP Morgan, Morgan Stanley and UBS are global coordinators on the trade, with Barclays, Bank of America, BNP ...
Pfizer to sell about $3.25 bln stake in Sensodyne-maker Haleon, bookrunner says
Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...
Dr Reddy's completes acquisition of Haleon's global NRT portfolio
DRL's Swiss subsidiary completed the acquisition through the purchase of shares of Northstar Switzerland SARL, a Haleon group ...